Pfizer under pressure to resolve shortage of life-saving EpiPen

Mylan is becoming increasingly frustrated with Pfizer's inability to tackle the shortage of the life-saving EpiPen, which has been placed on the FDA's official shortage list, the Financial Times reports.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.